Anzeige
Mehr »
Montag, 30.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
526 Leser
Artikel bewerten:
(2)

Proventus Bioscience Breaks Ground on Its New Production Facility and Expansion of Its Laboratories and Fermentation Plant

Proventus Bioscience continues to be a leading innovator and producer of bio-based products that improve crop yields, shorten growing periods, and create healthier, more resilient soils for organic farmers, greenhouse growers and mainstream production farmers. Its impact has been recognized globally.

MONTREAL, QC / ACCESSWIRE / June 13, 2023 / Proventus Bioscience, a biotech company that produces sustainable biological microorganisms for use by various industries, announced the start of construction of its new 20,000-square-foot production plant and corporate headquarters at 4455 Griffith St., Saint-Laurent, QC.

Proventus Bioscience, Tuesday, June 13, 2023, Press release picture



Proventus' new 20,000-square foot facility is designed to be compliant with current Good Manufacturing Practices (camps) required by the food industry that include bio-infused products for probiotics, agriculture formulations, and treatments for waste management and pollution control. GMP was first developed by the World Health Organization in 1968 and has since evolved and expanded, with 100 countries adopting the provisions in their own requirements.

Speaking at the company's official announcement, the founders of Proventus, Mr. Vincent Delorenzo and Peter Bozel, commented on the company's incredible growth over the last seven years as proof that the company's technology is widely accepted by the industry. The demand for Proventus' products is what propelled this incredible expansion:

"The inauguration of this facility will take place sometime in August and will give Proventus a launching pad from [which to] introduce novel first-in-class sustainable microbial formulations that can be used for a wide spectrum of industries and add many new novel products such as biostimulants and bio-protectants for use in agriculture and remediation of polluted soils.

"Our plans and pipeline for new products are ambitious but attainable because our technology solution is unique in the remediation of polluted waters and soils and for enhancement of biorational agricultural production practices by developing biologicals as compliments or replacement for chemical fertilizers and plant protectants. Its efficacy is being [proven daily] in farmers' fields and in tests conducted in laboratories and greenhouses at respected research institutions throughout Canada.

"Proventus' core technology is in constant development. We have acquired the most up-to-date fermentation equipment, solid-state fermenters, high-capacity freeze dryers and methods to formulate and stabilize viruses, bacteria, and fungi for optimal activity under all environmental conditions."

Internationally recognized plant scientist Dr. George Lazarovits heads the Proventus Scientific Advisory Board.

Visit proventusbioscience.com or call 438-387-1117 for more information.

About Proventus Bioscience Inc.
Proventus Bioscience Inc., based in Montreal, is a biotech company that develops sustainable biological products for the management of polluted environments and for use in sustainable agriculture. It has pioneered many other products with eco-positive solutions and continues to develop new innovations as a response to market changes on its own as well as with major partnerships.

Acknowledgment:
Proventus Bioscience would like to take this opportunity to thank the Economic Development Agency of Canada for the Regions of Quebec for its financial support. REGI is a national funding program that supports the economic growth of businesses and regions through innovation.

Contact Information

Vincent DeLorenzo
Founding Member
info@proventusbioscience.com

SOURCE: Proventus Bioscience

.

View source version on accesswire.com:
https://www.accesswire.com/760895/Proventus-Bioscience-Breaks-Ground-on-Its-New-Production-Facility-and-Expansion-of-Its-Laboratories-and-Fermentation-Plant

© 2023 ACCESS Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Diesen Artikel auf Deutsch lesen
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.